Pdf prego presentation of graves orbitopathy study. Graves ophthalmopathy an overview sciencedirect topics. Thyroidassociated orbitopathy tao, also referred to as graves ophthalmopathy, graves orbitopathy, and thyroid eye disease, is a constellation of signs and symptoms resulting from chronic autoimmunerelated orbital inflammation. The management of patients with graves orbitopathy go and severe dysthyroid optic neuropathy don, refractory to corticosteroid therapy and radiation therapy is a major challenge. Clinical assessment of patients with graves orbitopathy. Predictive score for the development or progression of. Graves orbitopathy and hypercholesterolemia full text. The bodys autoimmune process is involved in the development of graves disease gd, which is manifested by an overactive thyroid gland. Pdf the medical treatment of graves orbitopathy go is usually reserved to moderate to severe disease. Dickinson,3 anja eckstein,4 pat kendalltaylor,5 claudio marcocci,6 maarten p. Graves ophthalmopathy go, thyroid eye disease ted, or thyroid. The evaluation and treatment of graves ophthalmopathy ncbi. If the inline pdf is not rendering correctly, you can download the pdf file here. Graves ophthalmopathy, also known as thyroid eye disease ted, is an autoimmune inflammatory disorder of the orbit and periorbital tissues, characterized by upper eyelid retraction, lid lag, swelling, redness, conjunctivitis, and bulging eyes exophthalmos.
It is also known as thyroidassociated orbitopathy tao as it occasionally occurs in euthyroid or hypothyroid patients with chronic thyroiditis. Update on thyroidassociated ophthalmopathy with a special. The influence of juvenile graves ophthalmopathy on graves. Graves orbitopathy, ophthalmopathy, prevalence, incidence, epidemiology, rare disease. Oxygen free radicals and cytokines play a pathogenic role in graves orbitopathy. Insights into the pathogenesis of thyroidassociated. In patients with graves orbitopathy go, magnetic resonance imaging mri is a valuable tool to distinguish the acute inflammatory active disease from fibrotic. Graves orbitopathy go is an uncommon, disfiguring and disabling autoimmune condition and more than 90% of cases occur in patients presenting with hyperthyroidism due to graves disease. Graves ophthalmopathy and dermopathy sciencedirect. Orbital radiotherapy for graves ophthalmopathy thyroid. The european group on graves orbitopathy eugogo was established in order to promote better clinical care of patients with graves orbitopathy go 1, 2 and to facilitate research in this disease. Orbital radiation therapy for graves ophthalmopathy. In graves orbitopathy go, an associated psychosocial burden is present due to disfiguring proptosis andor diplopia, signs with significant impact on functional status and well. The il6 receptor antibody tocilizumab tcz has demonstrated efficacy in the treatment of this pathology.
What has not changed is the successful and attractive questionandanswer format of the book. Graves orbitopathy occurs sexindependently in an autoimmune. Infiltration of immune effector cells and thyroidantigenspecific and integration with b cells, plasmas cells and macrophages cells into thyroid and tsh and igfrecptor receptors carrying tissues tshr is found on thyroid epithelial cells, adipocytes and bone cells. Although the primary autoantigens and precise mechanisms underlying the association between go and aitd remain unclear, tsh receptors are thought to be the primary target of autoimmune reactions in go patients. Eugogo aims to contribute towards understanding the pathogenesis of graves orbitopathy and improving the management of patients, through collaborative scientific basic and clinical research, contribute towards education, teaching and training of health professionals involved in the care of patients with graves orbitopathy and raise funds to support its activities. Graves ophthalmopathy also known as graves orbitopathy or thyroid eye disease occurs as a spectrum of disease ranging from subclinical enlargement of the extraocular muscles in most patients with this condition to disfiguring and visionthreatening involvement of the entire orbit in an unfortunate few. Thyroid associated orbitopathy tao is a common diagnosis encountered by ophthalmologists and oculoplastic surgeons. The investigators have recently observed retrospectively that the occurrence of graves orbitopathy in patients with graves disease is less frequent in patients with normal cholesterol levels, in line with another recent observation suggesting that statins play a protective role in graves patients from developing graves orbitopathy. Consensus statement of the european group on graves. Selenium and the course of mild graves orbitopathy nejm.
Introductiongraves orbitopathy is the extra thyroidal manifestation of graves disease and the most common cause of exophthalmos. Update on diagnosis and therapy graves orbitopathy go is an autoimmune disorder representing the most frequent extrathyroidal manifestation of graves disease. Pdf the epidemiology of graves orbitopathy go may be changing. Consensus statement of the european group on graves orbitopathy eugogo on management of graves orbitopathy luigi bartalena,1 lelio baldeschi,2 alison j. It is associated with graves disease, a condition that causes over activity of the thyroid gland the gland that sets the rate of metabolism in the body.
Graves orbitopathy go is an autoimmune disease characterized by the presence of eyelid retraction, proptosis and restrictive strabismus. Management of go is often suboptimal, largely because available treatments do not target pathogenic mechanisms of the disease. It occurs most commonly in individuals with graves disease, and less commonly in individuals with hashimotos thyroiditis, or in. Orbitopathy definition of orbitopathy by medical dictionary. It is the most common extrathyroidal manifestation of graves. Graves orbitopathy go is the main extrathyroidal manifestation of graves disease, though severe forms are rare. Corticostereoids and conventional immunosuppressors are not always effective or well tolerated. Thyroidassociated ophthalmopathy tao is a condition associated with a wide spectrum of ocular changes, usually in the context of the autoimmune syndrome, graves disease. Intravenous glucocorticoids for graves orbitopathy. Pdf on jan 1, 2018, mario salvi and others published graves orbitopathy find, read and cite all the research you need on researchgate. The main goal of therapy for graves orbitopathy go is to restore visual function and to improve quality of life qol.
Update on advanced imaging options for thyroidassociated. Mourits,7 petros perros,8 kostas boboridis,9 antonella boschi,10. Equally applicable to north american clinicians and patients t he european group on graves orbitopathy eugogo. Graves ophthalmopathy go is an autoimmune inflammatory. Graves orbitopathy as a rare disease in europe orphanet journal. We developed a validated polish version of the goqol questionnaire goqolpl. In conclusion, sex does not predispose for autoimmune hyperthyroidism and associated go.
Eugogo the european group on graves orbitopathy eugogo. Graves orbitopathy is a condition associated with swelling of the tissue in the orbit, creating bulging of the eyes. Graves orbitopathy is an autoimmune process affecting the orbital tissues of patients with graves disease. Psychosocial morbidity of graves orbitopathy kahaly. Graves orbitopathy go is an autoimmune disorder of the orbit that is closely associated with autoimmune thyroid diseases aitd. Graves orbitopathy table of contents karger publishers. If untreated, go is characterised by an initial phase of gradual deterioration lasting 612 months, and then slow improvement lasting for 23 years. The disorder generally occurs in patients with graves hyperthyroidism, or a history thereof, but can also occur in euthyroid patients without a history of thyroid disease or in hypothyroid patients with hashimotos thyroiditis. Immunological aspects of graves ophthalmopathy hindawi.
The 2016 european thyroid associationeuropean group on. As an original version we used the english version of goqol, which consists of 15 questions summarised. Current understanding of the progression and management of. Orbital radiotherapy is a wellestablished method of treatment for severe graves ophthalmopathy, because of its antiinflammatory and locally. Tao has a varying clinical presentation that can include upper eyelid retraction, restrictive strabismus, proptosis, exposure keratopathy, and optic neuropathy. The eugogo consensus statement on the management of.
Mycophenolate mofetil mmf is a selective immunosuppressant used widely in many autoimmune diseases. Thyroidassociated ophthalmopathy taoa, aka thyroid eye disease or graves ophthalmopathy refers to several ocular manifestations related to the systemic. We have therefore surveyed and assessed the psychosocial morbidity of go. Thyroid associated orbitopathy tao, also known as graves orbitopathy go and thyroid eye disease ted, is a disabling and disfiguring. There were analyzed data visual acuity, proptosis, palpebral fissure measurements, clinical activity score cas, and the course of gd of 67 children who have been newly diagnosed with gd.
Thyroid eye disease, thyroid orbitopathy, graves eye, thyroidrelated eye disease all same condition. Since then, the book has become very popular and much has happened in the field to warrant a third edition. Graves ophthalmopathy go is an inflammatory disorder of the orbit that occurs in association with autoimmune thyroid disease. Populationbased data on the incidence and clinical presentation of moderate to severe graves orbitopathy go are scarce, and virtually nothing is known on the effect of. The disorder generally occurs in patients with graves hyperthyroidism, or a history thereof, but can also occur in euthyroid patients without a history of thyroid. The body of clinical evidence with teprotumumab includes topline positive results from the phase 3 confirmatory clinical trial, called optic treatment of graves orbitopathy thyroid eye disease to reduce proptosis with teprotumumab infusions in a randomized, placebocontrolled, clinical study, presented at the 2019 american association of clinical endocrinologists aace meeting, as well. A multidisciplinary approach questions and answers the significant progress in the understanding of the pathogenesis and the treatment of graves orbitopathy go has warranted a second edition of this book within three years of the first.
It is characterised by ocular pain, eyelid swelling, chemosis, proptosis and keratopathy. Attempts to understand the pathogenesis of thyroidassociated orbitopathy tao have failed, in part because of confounding features associated with its variable clinical presentation. Graves ophthalmopathy is the most common extrathyroid manifestation in patients with graves disease, based on inflammatory and autoimmune conditions in. The current version is designed for office use and can be downloaded from the iteds. Compared with placebo recipients, seleniumtreated patients reported significantly better graves orbitopathy related quality of life, and several ophthalmologic endpoints also were judged to be better according to examinations performed by ophthalmologists blinded to treatment group. Inclusion criteria were untreated gh, absence of overt go and planned treatment with antithyroid drugs for 18 months. Definition of gh was a decreased tsh, elevated ft4 andor ft3 and. As t cells infiltrate in orbital tissues plays a central role in the pathogenesis of go, the administration of rabbit antithymocyte globulin ratg may be considered as a potential new method of. As the mechanism for ophthamoplegia and optic neuropathy is the orbital swelling leading to mechanical restriction of ocular muscles and compression of optic nerve, one expects.
Thyroidassociated orbitopathy tao is a selflimiting autoimmune condition usually associated with graves disease. Pdf imaging studies for diagnosing graves orbitopathy. In the absence of a more complete insight into disease mechanisms, no specific and effective therapy can be. Practical guidelines management of graves ophthalmopathy. Graves orbitopathy go is an autoimmune condition, which is associated with poor clinical. In this study, the therapeutic benefit of rt was evaluated in terms of patients. The aim of immunosuppressive treatment in graves orbitopathy go is to decrease inflammation and congestion of the orbital tissue, thereby trying to prevent clinical progression of the autoimmune disease 14. This article provides an overview of the pathogenesis, diagnosis and management of graves orbitopathy go, an inflammatory eye disease commonly associated with graves disease. Graves ophthalmopathy go is an autoimmune condition primarily managed with prolonged courses of glucocorticoids, which can be associated with significant side effects. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Preliminary studies have shown that mmf is effective in the treatment of active go. Ten years ago, the first edition of graves orbitopathy.
612 360 1360 280 1071 447 1290 1590 245 483 1454 216 1056 227 811 443 342 1397 615 447 729 712 1366 985 102 807 77 1369 1077 1162 1516 989 1574 83 177 954 892 772 465 137 281 1013 1211 1232